午夜插插,噜噜噜影院,啪啪伊人网,欧美熟夫,景甜吻戏视频,男人强操性感蕾丝美女视频在线网站,日本美女跳舞视频

Changsha MOL Changes Biotechnology Co., Ltd.

Changsha MOL Changes Biotechnology Co., Ltd.

Main products: Peptide synthesis,Peptide modification,Protein and peptide labeling,Cellular response

Current Location: HOME >> Product
Product Categories
Changsha MOL Changes Biotechnology Co., Ltd.
Country: China
Tel:
Mobile: 19375158599
E-mail: info@molchanges.com
QQ:
Skype: Chat Now!
Address: Changsha Longping Bio-Industrial Park Provincial Research Center Factory
MOL Changes has unique technical capabilities in peptide synthesis, peptide modification, protein and peptide labeling, and cellular reactions. The company's technical staff comes from the fields of organic chemistry and biology, and the technical leadership consists of graduate students and PhDs. The company has mastered a wide range of peptide synthesis methods, including solid-phase peptide synthesis, liquid-phase peptide synthesis, combined liquid-solid peptide synthesis, reverse solid-phase peptide synthesis and microbial fermentation methods. microbial fermentation methods. We offer a wide range of synthetic R&D services for drug discovery, biological research and bioengineering, and provide scientists with viable pathways in the process of new drug development. The value of peptide synthesis we provide goes beyond long sequences and high purity, as we have unique techniques for solving complex and difficult peptide sequences, overcoming compatibility issues during peptide synthesis, and assisting our clients with a comprehensive optimization strategy for the research process. Our R&D, synthesis, purification, lyophilization, and testing are all done in sterile laboratories. Currently, we have set up research laboratories and branch offices in Changsha, Zhuzhou, and Hong Kong, and our customers are mainly from the United States, Canada, Russia, the United Kingdom, Australia, Sweden, Norway, and South Korea, which include biochemistry colleges, biochemical research institutes, medical research institutes, and bio-scientists. In the future, MOL Changes will continue to focus on technology research and development, with the aim of becoming a leading company in the field of single peptide products, and establishing a strong technological and cost advantage in the field, which will help our customers to occupy a dominant position in the market.
Product Name MF CAS Details
Tau Peptide (379-408) C140H228N44O46 1246357-53-8 Details
Arg8]-Vasopressin (4-9) C25H44N12O8S 96027-30-4 Details
(Deamino-Cys1,Val4,D-Arg8)-Vasopressin C46H65N13O11S2 43157-23-9 Details
Gly-Neuroendocrine Regulatory Peptide-3 (human, mouse, rat) C146H234N46O52 1815618-19-9 Details
Charybdotoxin C176H277N57O55S7 95751-30-7 Details
LQEQ-19 (mouse, rat) C106H165N29O34 322644-72-4 Details
AQEE-30 (human) C157H252N48O56 160046-70-8 Details
H-Leu-Ser-Lys-Leu-OH C21H41N5O6 162559-45-7 Details
TRH C16H22N6O4 24305-27-9 Details
ω-Conotoxin MVIIC|OMEGA-CONOTOXIN MVIIC C106H178N40O32S7 147794-23-8 Details
(d(CH2)51,D-Phe2,Ile4,Ala-NH2)-Vasopressin C53H77N13O10S2 99835-78-6 Details
TRH-AMC C26H28N6O6 190836-86-3 Details
u-Conotoxin GIIIA C100H170N38O32S6 129129-65-3 Details
LSKL, Inhibitor of Thrombospondin TSP-1 C21H42N6O5 283609-79-0 Details
Tertiapin C106H180N34O23S5 58694-52-3 Details
AQEE-30 (mouse, rat) C156H245N47O56 323185-80-4 Details
T-peptide C92H171N45O18 2022956-62-1 Details
Urotensin II,human C64H85N13O18S2 251293-28-4 Details
SB-710411 C54H66Cl2N12O8S2 209006-05-3 Details
(1-Adamantaneacetyl1,D-Tyr(Et)2,Val4,Abu6, Arg8.9)-Vasopressin C62H94N16O11 112465-00-6 Details
Stichodactyla helianthus Neurotoxin (ShK) C169H274N54O48S7 172450-46-3 Details
(d(CH2)51,D-Tyr(Et)2,Val4,Arg8,des-Gly9)-Vasopressin C51H74N12O10S2 90332-82-4 Details
Chlorotoxin C158H249N53O47S11 163515-35-3 Details
Copeptin (human) C177H279N49O58 78362-34-2 Details
Tertiapin Q C106H175N35O24S4 910044-56-3 Details
Lys-Trp-Lys-(Ser(GlcNAc-β-D)400)-Tau Peptide (388 - 411)-Lys-Lys(biotinyl) amide 2022974-40-7 Details
(d(CH2)51,D-Ile2,Ile4,Arg8)-Vasopressin C49H77N13O10S2 88686-53-7 Details
Mast Cell Degranulating (MCD) Peptide HR-2 C77H135N17O14 80388-04-1 Details
Biotinyl-Tau Peptide (306-336) (Repeat 3 Domain) (human) C153H250N44O44S2 2022956-58-5 Details
α-Conotoxin EI (free acid) C83H124N26O28S5 1926163-14-5 Details
Urotensin II-Related Peptide (human, mouse, rat) C49H64N10O10S2 342878-90-4 Details
(Dap22)-Stichodactyla helianthus Neurotoxin (ShK) C166H274N54O48S7 220384-25-8 Details
(Deamino-Cys1,D-Orn8)-Vasopressin C45H62N12O12S2 60498-04-6 Details
(Phenylac1,D-Tyr(Et)2,Lys6,Arg8,des-Gly9)-Vasopressin C54H76N14O11 129520-65-6 Details
Urotensin II (goby) C62H84N14O17S2 9047-55-6 Details
ω-Agatoxin TK C215H337N65O70S10 158484-42-5 Details
d[Cha4]-AVP C50H71N13O11S2 500170-27-4 Details
Tau Peptide (307-321) C78H133N19O23 330456-50-3 Details
α-Conotoxin MI C58H88N22O17S4 88217-10-1 Details
ω-Agatoxin IVA C215H337N65O70S10 145017-83-0 Details
Neuroendocrine Regulatory Peptide-2 (human) 1872441-23-0 Details
Mast Cell Degranulating (MCD) Peptide C110H192N40O24S4 32908-73-9 Details
Boc-Pressinoic acid C38H50N8O12S2 72287-67-3 Details
Sarafotoxin S6b C110H159N27O34S5 120972-53-4 Details
Biotin-Ahx-ω-Conotoxin GVIA C136H207N41O46S7 151928-23-3 Details
Conantokin G (free acid) C88H137N25O45 133628-78-1 Details
(d(CH2)51,Tyr(Me)2,Arg8)-Vasopressin C52H74N14O12S2 73168-24-8 Details
TRH-βNA C26H28N6O4 73644-58-3 Details
(Propionyl1,D-Tyr(Et)2,Val4,Abu6,Arg8.9)-Vasopressin C53H82N16O11 121250-95-1 Details
(Lys4)-Sarafotoxin C C105H153N27O36S5 1219444-22-0 Details
(d(CH2)51,Tyr(Et)2,Val4,Arg8,des-Gly9)-Vasopressin C51H74N12O10S2 90332-81-3 Details
u-Conotoxin GIIIB| MU-CONOTOXIN GIIIB C101H175N39O30S7 140678-12-2 Details
Urotensin I C210H340N62O67S2 83930-33-0 Details
Neuroendocrine Regulatory Peptide-1 (rat) C110H180N32O38 954420-51-0 Details
Copeptin (rat) C183H307N57O61 86280-64-0 Details
Toxin GaTx1 1926163-15-6 Details
Tau Peptide (512-525) amide C51H77N15O21 2022956-61-0 Details
((R)-4-Hydroxy-4-methyl-Orn7)-Phalloidin C35H49N9O10S 87876-22-0 Details
Biotin-(Arg8)-Vasopressin C56H79N17O14S3 126703-17-1 Details
Phalloidin C35H48N8O11S 17466-45-4 Details
H-His-Pro-NH2 C11H18BrN5O2 59760-04-2 Details
Tau Peptide (306-336) (Repeat 3 Domain) C143H236N42O42S 330456-26-3 Details
TRH-Gly C18H24N6O6 85344-77-0 Details
3-(4-Azidophenyl)propionyl1,D-Tyr(Me)2,Arg6,Arg8,Tyr-NH)-Vasopressin C63H84N20O13 157702-46-0 Details
Mast Cell Degranulating (MCD) Peptide HR-1 C71H133N19O15 80533-94-4 Details
6-FAM-AEEAc-Stichodactyla helianthus Neurotoxin (ShK) C40H41N5O16S 1927927-42-1 Details
(Deamino-Pen1,Val4,D-Arg8)-Vasopressin C48H69N13O11S2 64158-84-5 Details
(PEN)-UROTENSIN II (4-11) C52H68N10O12S2 473902-31-7 Details
(d(CH2)51,D-Ile2,Ile4,Arg8,Ala-NH2)-Vasopressin C50H79N13O10S2 114455-29-7 Details
(Ser(PO3H2)396.404)-Tau Peptide (379-408) C140H230N44O52P2 2022956-60-9 Details
Tau Peptide (337-368) (Repeat 4 Domain) C150H248N44O50 330456-27-4 Details
ω-Conotoxin GVIA C120H182N38O43S6 106375-28-4 Details
Neuroendocrine Regulatory Peptide-2 (rat) 1872441-24-1 Details
H-Leu-Ser-Ala-Leu-OH C18H34N4O6 169249-03-0 Details
(Lys1015.1024)-Thrombospondin-1 (1015-1024) (human, bovine, mouse) C68H105N17O12S 178921-95-4 Details
Iberiotoxin C179H274N50O55S7 129203-60-7 Details
Arg8]-Conopressin G C44H71N17O10S2 130836-24-7 Details
d[Leu4,Lys8]-VP C47H67N11O11S2 42061-33-6 Details
Tau Peptide (268-282) C72H125N23O19 330456-37-6 Details
(d(CH2)51,Tyr(Et)2,Val4,Arg8,des-Gly-NH2)-Vasopressin C51H73N11O11S2 110567-67-4 Details
Ac-Tyr-Lys-NH2 C17H26N4O4 270597-64-3 Details
(Pyr1)-Urotensin II (rat) C77H102N18O20S2 405136-99-4 Details
(3,5-Diiodo-Tyr2,Arg8)-Vasopressin C46H63I2N15O12S2 63441-67-8 Details
Substance P (7-11) C31H44N6O5S 51165-05-0 Details
Sarafotoxin S6a C105H156N28O34S5 126738-34-9 Details
Tau Peptide (472-487)-PEG6-(507-526) (human) 2243219-84-1 Details
(Arg8)-Vasopressin (free acid) C46H64N14O13S2 25255-33-8 Details
(Phenylac1,D-Tyr(Me)2,Arg6.8,Tyr-NH2)-Vasopressin C62H83N17O13 135447-36-8 Details
Neuroendocrine Regulatory Peptide-1 (human) C113H192N36O39 954420-50-9 Details
(Deamino-Cys1,Lys8)-Vasopressin C46H64N12O12S2 2989-84-6 Details
(Ser(PO3H2)202,Thr(PO3H2)205)-Tau Peptide (194-213) C81H133N29O36P2 2022956-55-2 Details
Tau Peptide (306-317) C65H109N15O18 1003007-59-7 Details
Tau Peptide (74-102) (Exon 3/Insert 2 Domain) C124H198N34O46 1322695-34-0 Details
(Deamino-Pen1,Tyr(Me)2,Arg8)-Vasopressin C49H70N14O12S2 67269-08-3 Details
(Deamino-Cys1,β-(3-pyridyl)-D-Ala2,Arg8)-Vasopressin C45H63N15O11S2 136105-89-0 Details
Tau Peptide (323-335) C60H103N21O20 2022956-59-6 Details
α-Dendrotoxin C305H480N98O85S6 74504-53-3 Details
des-Gly9 NH2 Vasopressin C44H61N13O12S2 37552-33-3 Details
(Phenylac1,D-Tyr(Me)2,Arg6.8,Lys-NH2)-Vasopressin C59H86N18O12 148565-73-5 Details
Sarafotoxin 6c C103H147N27O37S5 121695-87-2 Details
Product Total: Product Page:
3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53